EpiCast Report: Age-Related Macular Degeneration – Epidemiology Forecast to 2026
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Age-related macular degeneration (AMD) is a progressive eye condition that is characterized by the gradual deterioration of the macula, which is the area of the retina responsible for central vision. AMD is the most common cause of significant irreversible vision loss among the elderly.
GlobalData epidemiologists utilized national databases and robust peer-reviewed journal articles to build the forecast for the total prevalent cases (including both diagnosed and undiagnosed) as well as the diagnosed incident cases of AMD, early AMD, late AMD, late dry AMD, late wet AMD, and large drusen in the 7MM.
the total prevalent cases of AMD in the 7MM will increase from 71,787,702 cases in 2016 to 82,997,296 cases in 2026, at an Annual Growth Rate (AGR) of 1.56% over the forecast period. Throughout the forecast period, Japan will have the highest number of total prevalent cases of AMD, followed by Italy. The total prevalent cases of AMD in Japan and Italy combined will make up approximately 39.28% of the total prevalent cases of AMD in the 7MM. GlobalData epidemiologists attribute the growth in the total prevalent cases of AMD in the 7MM to the changing population demographics in the respective markets.
Scope
The Age-related Macular Degeneration (AMD) EpiCast Report and EpiCast Model provide an overview of the risk factors and global trends of AMD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
The report also includes a 10-year epidemiological forecast for the total prevalent cases of AMD, early AMD, late AMD, late dry AMD, and late wet AMD, all of which are segmented by sex and age (ages 50 years and older) in these markets. GlobalData epidemiologists also provided the diagnosed incident cases of AMD, early AMD, late AMD, late dry AMD, and late wet AMD, all of which are segmented by sex and age (ages 50 years and older). Additionally, the report includes a 10-year epidemiological forecast for the total prevalent cases and diagnosed incident cases of large drusen (≥125 µm) segmented by sex and age (ages 50 years and older) in these markets.
The AMD epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
The EpiCast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.
Reasons to Buy
The AMD EpiCast series will allow you to:
Develop business strategies by understanding the trends shaping and driving the global AMD market.
Quantify patient populations in the global AMD market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for AMD therapeutics in each of the markets covered.
Understand magnitude of AMD population by type.
Table of Contents
Table
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.